{"disease":{"id":"alk-gene-rearrangement-or-ros1-gene-rearrangement","name":"alk gene rearrangement or ros1 gene rearrangement"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03718117","title":"Descriptive Observational Study ALK-2016-CPHG","phase":"","overall_status":"COMPLETED","enrollment_count":73,"lead_sponsor_name":"Pfizer","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}